WorldQuant Millennium Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$206M Buy
3,392,094
+1,222,514
+56% +$71.3M 0.79% 23
2025
Q4
$117M Sell
2,169,580
-991,860
-31% -$47.7M 0.45% 51
2025
Q3
$143M Buy
3,161,440
+3,141,932
+16,106% +$147M 0.62% 38
2025
Q2
$903K Sell
19,508
-544,370
-97% -$26.7M ﹤0.01% 405
2025
Q1
$34.4M Buy
+563,878
New +$32.9M 0.22% 130
2024
Q4
Sell
-553,656
Closed -$28.6M 439
2024
Q3
$28.6M Buy
553,656
+253,040
+84% +$11.9M 0.21% 126
2024
Q2
$12.5M Buy
+300,616
New +$13.5M 0.11% 195
2024
Q1
Sell
-760,013
Closed -$39M 351
2023
Q4
$39M Buy
760,013
+196,052
+35% +$10.3M 0.55% 54
2023
Q3
$32.7M Buy
563,961
+36,530
+7% +$2.24M 0.51% 64
2023
Q2
$33.7M Sell
527,431
-172,534
-25% -$11.6M 0.57% 46
2023
Q1
$48.5M Buy
699,965
+624,930
+833% +$44.1M 0.9% 18
2022
Q4
$5.4M Buy
+75,035
New +$5.66M 0.12% 203
2022
Q3
Sell
-36,837
Closed -$2.84M 323
2022
Q2
$2.84M Sell
36,837
-198,439
-84% -$15.1M 0.08% 233
2022
Q1
$17.2M Sell
235,276
-338,325
-59% -$22.7M 0.42% 77
2021
Q4
$35.8M Buy
573,601
+208,908
+57% +$12.3M 0.71% 29
2021
Q3
$21.6M Sell
364,693
-112,768
-24% -$7.43M 0.47% 63
2021
Q2
$31.9M Sell
477,461
-167,596
-26% -$10.9M 0.71% 37
2021
Q1
$40.7M Buy
645,057
+69,874
+12% +$4.35M 0.86% 14
2020
Q4
$35.7M Hold
575,183
0.78% 17
2020
Q3
$34.7M Buy
575,183
+197,498
+52% +$11.9M 0.82% 20
2020
Q2
$22.2M Buy
377,685
+141,378
+60% +$8.46M 0.51% 51
2020
Q1
$13.2M Sell
236,307
-14,034
-6% -$858K 0.32% 100
2019
Q4
$16.1M Sell
250,341
-491,937
-66% -$28.2M 0.31% 115
2019
Q3
$37.6M Sell
742,278
-1,710,706
-70% -$80.4M 0.73% 36
2019
Q2
$111M Buy
2,452,984
+846,212
+53% +$39.4M 2.12% 2
2019
Q1
$76.7M Buy
1,606,772
+818,362
+104% +$40.8M 1.82% 3
2018
Q4
$41M Buy
788,410
+223,138
+39% +$12M 1.21% 11
2018
Q3
$35.1M Sell
565,272
-125,697
-18% -$7.46M 1.18% 13
2018
Q2
$38.2M Buy
+690,969
New +$37.3M 1.47% 6

Other funds holding BMY

WorldQuant Millennium Advisors's BMY Position: Q1 2026 in Review

WorldQuant Millennium Advisors increased its Bristol-Myers Squibb (BMY) stake by 56% in Q1 2026, buying an estimated $71.3M and bringing the position to 3,392,094 shares worth $206M. The position accounts for 0.79% of the portfolio, ranked #23.

WorldQuant Millennium Advisors first reported a position in BMY in Q2 2018 and has held it in 29 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • WorldQuant Millennium Advisors held 3,392,094 shares of Bristol-Myers Squibb worth $206M as of Q1 2026.
  • WorldQuant Millennium Advisors bought 1,222,514 Bristol-Myers Squibb shares in Q1 2026, an estimated $71.3M.
  • Bristol-Myers Squibb made up 0.79% of WorldQuant Millennium Advisors's portfolio in Q1 2026, its #23 holding.
  • WorldQuant Millennium Advisors first reported a position in Bristol-Myers Squibb in Q2 2018 and has held it in 29 quarters since.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q1 2026, filed 15 May 2026.